Prudential Financial
ZYME icon

Prudential Financial’s Zymeworks ZYME Stock Holding History

Prudential Financial’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
7,940
-14,030
-64% -$356K ﹤0.01% 2219
2026
Q1 		$550K Buy
21,970
+9,215
+72% +$218K ﹤0.01% 1825
2025
Q4 		$336K Sell
12,755
-20,635
-62% -$450K ﹤0.01% 1945
2025
Q3 		$570K Sell
33,390
-11,575
-26% -$166K ﹤0.01% 1885
2025
Q2 		$564K Buy
44,965
+2,395
+6% +$28.5K ﹤0.01% 1901
2025
Q1 		$507K Buy
42,570
+22,910
+117% +$312K ﹤0.01% 1833
2024
Q4 		$288K Buy
+19,660
New +$275K ﹤0.01% 1996
2024
Q3 		– Sell
-43,160
Closed -$367K – 2808
2024
Q2 		$367K Buy
43,160
+2,900
+7% +$25.8K ﹤0.01% 2297
2024
Q1 		$424K Sell
40,260
-196,000
-83% -$2.18M ﹤0.01% 2225
2023
Q4 		$2.45M Buy
236,260
+15,550
+7% +$124K ﹤0.01% 1308
2023
Q3 		$1.4M Buy
220,710
+195,900
+790% +$1.45M ﹤0.01% 1589
2023
Q2 		$214K Buy
+24,810
New +$222K ﹤0.01% 2416

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Prudential Financial's ZYME Position: Q2 2026 in Review

Prudential Financial reduced its Zymeworks (ZYME) stake by 64% in Q2 2026, selling an estimated $356K and leaving 7,940 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2219.

Prudential Financial first reported a position in ZYME in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.45M in Q4 2023. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Prudential Financial held 7,940 shares of Zymeworks worth $208K as of Q2 2026.
  • Prudential Financial sold 14,030 Zymeworks shares in Q2 2026, an estimated $356K.
  • Zymeworks made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2219 holding.
  • Prudential Financial first reported a position in Zymeworks in Q2 2023 and has held it in 12 quarters since.
  • Prudential Financial's Zymeworks position peaked at $2.45M in Q4 2023.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.